Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01352598 · ClinicalTrials.gov registry record · NA

Stereotactic Body Radiotherapy for Prostate Cancer

A NA study, sponsored by Mercy Research.

Completed
Registry status
NA
Development phase
84
Enrollment target

NCT01352598 is a NA study that has completed, run by Mercy Research. The registered enrollment target is 84 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01352598, a NA study, has completed, sponsored by Mercy Research.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target

Study Summary

This study will evaluate the local control rate as well as acute and late toxicity rates of stereotactic body radiotherapy (SBRT) for the treatment of organ confined prostate cancer.

Interventions

  • RADIATION stereotactic body radiotherapy

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2011-06
Est. Completion 2019-04
Phase NA

Sponsor

Mercy Research

14 total trials

What the Registry Record Tells You About NCT01352598

The ClinicalTrials.gov registry entry for NCT01352598 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mercy Research, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which stereotactic body radiotherapy is the first listed.

NCT01352598 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01352598 about?

NCT01352598 is a clinical study titled "Stereotactic Body Radiotherapy for Prostate Cancer". This study will evaluate the local control rate as well as acute and late toxicity rates of stereotactic body radiotherapy (SBRT) for the treatment of organ confined prostate cancer.

What is the current status of trial NCT01352598?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2011-06. Estimated completion is 2019-04.

What interventions are being tested in trial NCT01352598?

The interventions under investigation include: stereotactic body radiotherapy (RADIATION).

Who is sponsoring clinical trial NCT01352598?

This trial is sponsored by Mercy Research, which has 14 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.